早期干预认知衰老与草补充剂的早期干预
Robert Krikorian1, Marcelle D Shidler1, Suzanne S Summer2
1Department of Psychiatry & Behavioral Neuroscience, University of Cincinnati Academic Health Center, Cincinnati, OH 45267, USA.
Nutrients
|October 28, 2023
概括
在中年成人中,每天摄入草粉可以改善记忆力和减少抑郁症状,这表明它在降低痴呆风险方面发挥了作用. 需要进一步研究代谢益处.
科学领域:
- 神经科学是一个神经科学.
- 公共卫生 公共卫生
- 营养科学 营养科学
背景情况:
- 晚年痴呆症,包括阿尔茨海默病 (AD),在没有有效治疗的情况下,构成了重大的公共卫生挑战.
- 神经退行性疾病在几十年内发展,风险因素如胰岛素耐药性在中年出现.
- 饮食干预措施,如果消费,可能会影响新陈代谢和认知,潜在地减轻痴呆风险.
研究的目的:
- 调查每日全果草粉补充剂对中年成人胰岛素耐药性和主观认知衰退的认知功能和代谢指标的影响.
主要方法:
- 一项为期12周的受控试验,涉及中年男性和女性超重,患有胰岛素抵抗和主观认知衰退.
- 参与者每天接受全果草粉,饮食记录证实坚持果戒断.
- 评估结果包括记忆干扰,抑郁症状,执行功能和代谢标记.
主要成果:
- 草补充剂显著减少记忆干扰 (p = 0.02) 和减少抑郁症状 (p = 0.04).
- 观察到的认知益处表明执行能力的改善.
- 没有检测到对代谢指标的显著影响,可能是由于样本大小,干预时间或安东剂量.
结论:
- 在中年开始服用草补充剂,可以通过改善认知功能和情绪来降低痴呆风险.
- 需要进一步研究延长干预期,更大的队列和多种剂量,以充分阐明草摄入在老年人群中的认知和代谢益处.
相关概念视频
Cognitive Development During Adulthood
125
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
125
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
131
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
131
Alzheimer's Disease: Treatment
200
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
200
Alzheimer's Disease: Overview
500
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
500
Aging
59
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
59


